EEG Archives • Fragile X Research - FRAXA Research Foundation

FRAXA Funded Researchers Present at MA Fragile X Conference

FRAXA Research Foundation Carol Wilkinson, MD, PhD, Clinical Trials, Craig Erickson, MD, Recap April 9, 2018April 30, 2018AZD7325, EEG

On Saturday Boston Children’s Hospital (BCH) hosted a fragile X educational conference, Success Strategies for Individuals and Families Impacted by Fragile X and two of our funded researchers, Dr. Craig Erickson, and Carol Wilkinson, MD, PhD, presented giving an update on their current fragile X clinical trials. Both being funded by FRAXA.

Now Recruiting: Clinical Study of EEG for Young Boys at Boston Children’s Hospital

FRAXA Research Foundation Clinical Trials, Recruiting, Research Updates March 27, 2018March 29, 2018EEG

Dr. Carol Wilkinson, MD PhD, and Dr. Charles Nelson, PhD, at the Labs of Cognitive Neuroscience at Boston Children’s Hospital are recruiting young boys with fragile X syndrome (FXS) to participate in a study investigating how differences in brain activity affect learning, language, and behavior in FXS. If we can determine what distinguishes one brain from another, and if a drug works with a particular neural marker or set of neural markers, this would permit matching drugs based on objective biological markers, a personalized medicine, rather than defaulting to the current method of trial and error.

Neural Markers of Cognitive, Language and Behavioral Deficits in Children with Fragile X

FRAXA Research Foundation 2017 Grants, Biomarkers, Boston Children's Hospital, Carol Wilkinson, MD, PhD, Charles A. Nelson, PhD, Clinical, Current Research Grants, Harvard University, Recruiting March 16, 2018April 28, 2018EEG

This 2017 grant of $90,000 over two years will enable Dr. Wilkinson to launch a study of EEG in young children with fragile X syndrome at Boston’s Children’s Hospital. She will work with principal investigator, Dr. Charles Nelson, who is a Professor of Pediatrics at Harvard Medical School and a specialist in cognitive neuroscience. Co-funded by the Autism Science Foundation and the Pierce Family Fragile X Foundation.

Combinatorial Drug Treatment in a Model of Fragile X Syndrome using Novel Biomarkers

FRAXA Research Foundation 2016 Grants, 2017 Grants, Biomarkers, Current Research Grants, Jonny Lovelace, PhD, Khaleel Razak, PhD, Treatment Targets, University of California at Riverside October 3, 2017March 22, 2018EEG, MMP9

With a $90,000 grant from FRAXA Research Foundation awarded over 2016-2017, University of California researchers Khaleel Razak, PhD, and Jonathan W. Lovelace, PhD, are exploring drug combinations to limit hypersensitivity to sounds in fragile X mice.